Genexine, Foreigners Net Buy 6,000 Shares... Stock Price -1.11%
Genexine has ranked among the top searched stocks for 5 days in the past month.
As of 10:30 AM on the 25th, Genexine is trading at 97,600 KRW, down 1.11% from the previous day. This represents a 30.83% increase compared to June 3. Genexine is known as a specialized company in biopharmaceutical development.
Today, foreigners are tentatively recorded as net buyers of 6,000 shares. Over the past 5 days, individual investors have net purchased 701,061 shares, while foreigners and institutions have net sold 60,109 shares and 75,721 shares, respectively.
On June 19, Genexine became a market issue with the news of the "first domestic" COVID-19 vaccine administered to humans, causing a "surge."


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
If They Fail Next Year, Bonus Drops to 97 Million Won... A Closer Look at Samsung Electronics DS Division’s 600M vs 460M vs 160M Performance Bonuses
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- Trump: "Talks in Final Stages," Iran Reviewing U.S. Proposal... Oil Prices Plunge 5% (Comprehensive)
- Room Prices Soar from 60,000 to 760,000 Won and Sudden Cancellations: "We Won't Even Buy Water in Busan" — BTS Fans Outraged
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.